Luther King Capital Management (LKCM)’s Apollo Endosurgery, Inc. APEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-272,727
Closed -$995K 613
2022
Q2
$995K Sell
272,727
-272,727
-50% -$1.29M 0.01% 389
2022
Q1
$3.3M Hold
545,454
0.02% 247
2021
Q4
$4.6M Hold
545,454
0.02% 215
2021
Q3
$4.94M Hold
545,454
0.02% 207
2021
Q2
$4.42M Hold
545,454
0.02% 226
2021
Q1
$3M Hold
545,454
0.02% 249
2020
Q4
$1.85M Hold
545,454
0.01% 294
2020
Q3
$922K Hold
545,454
0.01% 343
2020
Q2
$892K Sell
545,454
-3,000
-0.5% -$5.96K 0.01% 332
2020
Q1
$1.05M Hold
548,454
0.01% 294
2019
Q4
$1.56M Hold
548,454
0.01% 308
2019
Q3
$1.8M Hold
548,454
0.01% 284
2019
Q2
$1.78M Hold
548,454
0.01% 280
2019
Q1
$2.05M Hold
548,454
0.02% 266
2018
Q4
$1.89M Hold
548,454
0.02% 267
2018
Q3
$3.93M Hold
548,454
0.03% 208
2018
Q2
$3.83M Hold
548,454
0.03% 208
2018
Q1
$3.44M Hold
548,454
0.03% 217
2017
Q4
$3.07M Hold
548,454
0.03% 248
2017
Q3
$2.57M Buy
+548,454
New +$2.9M 0.02% 263

Other funds holding APEN

Luther King Capital Management (LKCM)'s APEN Position: Q3 2022 in Review

Luther King Capital Management (LKCM) sold out of Apollo Endosurgery, Inc. (APEN) in Q3 2022, closing a stake of 272,727 shares — an estimated $995K sold.

Luther King Capital Management (LKCM) first reported a position in APEN in Q3 2017 and held it in 20 quarters. The position peaked at $4.94M in Q3 2021. 53 funds tracked by Wall St. Rank hold APEN as of Q3 2022.

  • Luther King Capital Management (LKCM) reported no remaining Apollo Endosurgery, Inc. position as of Q3 2022 after selling out during the quarter.
  • Luther King Capital Management (LKCM) sold 272,727 Apollo Endosurgery, Inc. shares in Q3 2022, an estimated $995K.
  • Luther King Capital Management (LKCM) first reported a position in Apollo Endosurgery, Inc. in Q3 2017 and held it in 20 quarters.
  • Luther King Capital Management (LKCM)'s Apollo Endosurgery, Inc. position peaked at $4.94M in Q3 2021.
  • 53 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q3 2022.

Based on Luther King Capital Management (LKCM)'s 13F filing for Q3 2022, filed 10 Nov 2022.